Gilead Sciences, Inc. (GILD)

NMS – Real Time Price. Currency in USD

136.31

+0.54 (0.40%)

Market open: Aug 12, 2026, 10:47 AM EDT

135.07

-0.70 (-0.51%)

Previous after-hours: Aug 11, 2026, 7:51 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

29.45B

28.73B

27.06B

27.09B

Cost of goods sold

-6.23B

-6.25B

-6.02B

-5.66B

Gross Profit

23.22B

22.48B

21.04B

21.43B

Operating expenses (excl. COGS)

-11.40B

-11.82B

-11.29B

-10.67B

Operating Income

11.82B

10.66B

9.74B

10.76B

Non-operating income, total

-2.03B

-9.97B

-2.88B

-4.94B

Pretax income

9.80B

690M

6.86B

5.81B

Equity in earnings

Taxes

-1.29B

-210M

-1.25B

Non-controlling/minority interest

52M

26M

After tax other income/expense

Net income before discontinued operations

8.51B

480M

5.67B

4.59B

Discontinued operations

Net income

8.51B

480M

5.67B

4.59B

Dilution adjustment

Preferred dividends

Gilead Sciences, Inc. (GILD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gilead Sciences, Inc. (GILD)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Gilead Sciences, Inc. (GILD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gilead Sciences, Inc. (GILD)

Income Statement (Annual)

Income Statement (Annual)